Key terms
About GRTS
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest GRTS news
Apr 15
7:06am ET
Gritstone publishes interim results from Phase 1/2 study of SLATE
Apr 08
2:25pm ET
Buy Rating Affirmed: Gritstone Oncology’s Promising Growth and Technological Advancements
Apr 08
7:16am ET
Gritstone presents improvements to EDGE Platform at AACR 2024
Apr 04
11:03am ET
Biotech Alert: Searches spiking for these stocks today
Apr 03
10:52am ET
Biotech Alert: Searches spiking for these stocks today
Apr 03
5:32am ET
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Gritstone Oncology (GRTS)
Apr 02
7:04am ET
Gritstone $32.5M Spot Secondary priced at $1.50
Apr 02
6:16am ET
Gritstone price target raised to $5 from $4 at JMP Securities
Apr 02
12:25am ET
Buy Rating Affirmed for Gritstone Oncology Amid Promising Vaccine Trial Data and Regulatory Potential
Apr 01
4:12pm ET
Gritstone announces preliminary data from GRANITE study
Apr 01
4:12pm ET
Gritstone announces offering of common stock and warrants, no amount given
Mar 06
7:37am ET
Piper Sandler Sticks to Its Buy Rating for Gritstone Oncology (GRTS)
Mar 06
6:38am ET
Gritstone Oncology’s Strong Financials and Promising Vaccine Trials Fuel Buy Rating
Mar 06
6:20am ET
Analysts Conflicted on These Healthcare Names: ProKidney (PROK), Gritstone Oncology (GRTS) and MicroPort Scientific (OtherMCRPF)
Mar 06
12:30am ET
Analysts Offer Insights on Healthcare Companies: Neuronetics (STIM), Marinus (MRNS) and Gritstone Oncology (GRTS)
Mar 05
4:27pm ET
Gritstone reduced workforce by 40% in February
Mar 05
4:26pm ET
Gritstone reports FY23 EPS ($1.20) vs ($1.32) last year
Mar 01
7:03am ET
Buy Rating Affirmed for Gritstone Oncology Amid Strategic Workforce Reduction and Upcoming Trial Catalysts
Feb 29
4:19pm ET
Gritstone announces 40% reduction in workforce
Feb 28
9:57am ET
Apollo Global upgraded, Dell initiated: Wall Street’s top analyst calls
Feb 28
4:34am ET
Gritstone initiated with an Outperform at JMP Securities
Feb 28
12:40am ET
Analysts Are Bullish on These Healthcare Stocks: Gritstone Oncology (GRTS), Protagonist Therapeutics (PTGX)
Feb 13
7:30am ET
Analysts Offer Insights on Healthcare Companies: Healthcare Services (HCSG), Gritstone Oncology (GRTS) and Silence Therapeutics (SLN)
Feb 13
6:30am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: CymaBay Therapeutics (CBAY), G1 Therapeutics (GTHX) and Gritstone Oncology (GRTS)
Feb 13
5:13am ET
Buy Rating for Gritstone Oncology: Strategic Progress and Market Potential
Feb 12
8:20am ET
Gritstone Oncology Postpones Phase 2b COVID-19 Vaccine Trial
Feb 12
7:11am ET
Gritstone announces update to comparative Phase 2b COVID-19 trial
Jan 19
6:28am ET
5 Top Penny Stocks to Buy Now, According to Analysts – January 2024
Apr 14
10:17am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS
Apr 06
10:03am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS
Mar 21
3:24pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS
Mar 13
12:10pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTS
GRTS Financials
Key terms
Ad Feedback
GRTS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
GRTS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range